In the mechanism study, we revealed that DKI mice showed significantly altered gene expression patterns with involvement of Myc pathway activation, indicating a potential therapeutic target in DNMT3A mutation-related leukemia which needs to be further investigated. The gene discussed is MYC; the disease is leukemia.